Johnson, S., Buessing, M., O’Connell, T., Pitluck, S., & Ciulla, T. A. (2019). Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease. JAMA Ophthalmol.
Citação norma ChicagoJohnson, Scott, Marric Buessing, Thomas O’Connell, Sarah Pitluck, and Thomas A. Ciulla. "Cost-effectiveness of Voretigene Neparvovec-rzyl Vs Standard Care for RPE65-Mediated Inherited Retinal Disease." JAMA Ophthalmol 2019.
Citação norma MLAJohnson, Scott, et al. "Cost-effectiveness of Voretigene Neparvovec-rzyl Vs Standard Care for RPE65-Mediated Inherited Retinal Disease." JAMA Ophthalmol 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.